Suppr超能文献

免疫反应:严重脓毒症的治疗靶点

The immune response: targets for the treatment of severe sepsis.

作者信息

Bernard Aline M, Bernard Gordon R

机构信息

Division of Critical Care, Department of Pediatrics, University of Colorado School of Medicine, 13121 E 17th Avenue, MS 8414, Aurora, CO 80045-2535, USA ; Division of Pediatric Critical Care, Children's Hospital Colorado, 13123 East 16th Avenue, Aurora, CO 80045, USA.

出版信息

Int J Inflam. 2012;2012:697592. doi: 10.1155/2012/697592. Epub 2012 Dec 3.

Abstract

The clinical process of severe sepsis is characterized by extreme inflammation interlinked with potent stimulation of the coagulation cascade often followed by a state of relative immune paralysis. In this paper, we will review many of the potential therapies directed at various steps along the inflammatory cascade from modulation of inflammatory mediators eliciting the immune response, alteration of the host's immune response in both a stimulatory and depressive manner, and taming the overexuberant coagulation response triggered by the fierce coagulation-inflammation cycle. Finally, we will discuss further opportunities for research to improve our ability to design effective therapies.

摘要

严重脓毒症的临床过程的特征是极度炎症反应与凝血级联的强烈刺激相互关联,随后常出现相对免疫麻痹状态。在本文中,我们将综述许多针对炎症级联反应各个环节的潜在治疗方法,这些方法包括调节引发免疫反应的炎症介质、以刺激和抑制两种方式改变宿主的免疫反应,以及抑制由剧烈的凝血 - 炎症循环引发的过度凝血反应。最后,我们将讨论进一步的研究机会,以提高我们设计有效治疗方法的能力。

相似文献

1
The immune response: targets for the treatment of severe sepsis.
Int J Inflam. 2012;2012:697592. doi: 10.1155/2012/697592. Epub 2012 Dec 3.
2
Mediators of systemic inflammatory response syndrome and the role of recombinant activated protein C in sepsis syndrome.
Infect Dis Clin North Am. 2011 Dec;25(4):835-50. doi: 10.1016/j.idc.2011.07.009. Epub 2011 Sep 9.
3
[Physiopathology of severe sepsis].
Presse Med. 2004 Feb 28;33(4):256-61; discussion 269. doi: 10.1016/s0755-4982(04)98551-x.
5
The Pathogenesis of Sepsis and Potential Therapeutic Targets.
Int J Mol Sci. 2019 Oct 29;20(21):5376. doi: 10.3390/ijms20215376.
6
The use of activated protein C (drotrecogin alfa (activated)) in the treatment of severe sepsis.
Aust Crit Care. 2003 Nov;16(4):133-43. doi: 10.1016/s1036-7314(05)80036-0.
7
Host-directed Therapy: A New Arsenal to Come.
Comb Chem High Throughput Screen. 2021;24(1):59-70. doi: 10.2174/1386207323999200728115857.
8
An update on the pathophysiology of sepsis.
SADJ. 2004 May;59(4):163, 165.
10
The pathogenesis of sepsis. Factors that modulate the response to gram-negative bacterial infection.
Clin Chest Med. 1996 Jun;17(2):183-97. doi: 10.1016/s0272-5231(05)70308-7.

引用本文的文献

1
Gene Expression Profiles in Children With Suspected Sepsis.
Ann Emerg Med. 2020 Jun;75(6):744-754. doi: 10.1016/j.annemergmed.2019.09.020. Epub 2020 Jan 23.
2
Brain Death-Induced Inflammatory Activity is Similar to Sepsis-Induced Cytokine Release.
Cell Transplant. 2018 Oct;27(10):1417-1424. doi: 10.1177/0963689718785629. Epub 2018 Sep 20.
3
The Emperor Has No Clothes? Searching for Dysregulation in Sepsis.
J Clin Med. 2018 Aug 29;7(9):247. doi: 10.3390/jcm7090247.
4
Septicemia is associated with increased risk for dementia: a population-based longitudinal study.
Oncotarget. 2017 Sep 15;8(48):84300-84308. doi: 10.18632/oncotarget.20899. eCollection 2017 Oct 13.
5
Anti-Inflammatory Activity of the Essential Oil Citral in Experimental Infection with in a Model Air Pouch.
Evid Based Complement Alternat Med. 2017;2017:2505610. doi: 10.1155/2017/2505610. Epub 2017 Feb 21.
6
Role of cellular events in the pathophysiology of sepsis.
Inflamm Res. 2016 Nov;65(11):853-868. doi: 10.1007/s00011-016-0970-x. Epub 2016 Jul 8.
7
Increased risk of stroke after septicaemia: a population-based longitudinal study in Taiwan.
PLoS One. 2014 Feb 21;9(2):e89386. doi: 10.1371/journal.pone.0089386. eCollection 2014.

本文引用的文献

1
Emerging drugs for the treatment of sepsis.
Expert Opin Emerg Drugs. 2012 Sep;17(3):379-91. doi: 10.1517/14728214.2012.697151. Epub 2012 Jul 11.
2
Drotrecogin alfa (activated) in adults with septic shock.
N Engl J Med. 2012 May 31;366(22):2055-64. doi: 10.1056/NEJMoa1202290. Epub 2012 May 22.
3
Genetics and genomics in pediatric septic shock.
Crit Care Med. 2012 May;40(5):1618-26. doi: 10.1097/CCM.0b013e318246b546.
4
Treatment of neonatal sepsis with intravenous immune globulin.
N Engl J Med. 2011 Sep 29;365(13):1201-11. doi: 10.1056/NEJMoa1100441.
5
The evolving experience with therapeutic TNF inhibition in sepsis: considering the potential influence of risk of death.
Expert Opin Investig Drugs. 2011 Nov;20(11):1555-64. doi: 10.1517/13543784.2011.623125. Epub 2011 Oct 1.
6
Advances in the management of sepsis and the understanding of key immunologic defects.
Anesthesiology. 2011 Dec;115(6):1349-62. doi: 10.1097/ALN.0b013e31823422e8.
7
The use of steroids in the treatment of severe sepsis and septic shock.
Best Pract Res Clin Endocrinol Metab. 2011 Oct;25(5):735-43. doi: 10.1016/j.beem.2011.05.006.
8
Assessment of plasmatic immunoglobulin G, A and M levels in septic shock patients.
Int Immunopharmacol. 2011 Dec;11(12):2086-90. doi: 10.1016/j.intimp.2011.08.024. Epub 2011 Sep 13.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验